Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from MyCelx Technologies ( (GB:MYX) ).
MYCELX Technologies Corporation reported a revenue of approximately $1.7 million for the first half of 2025, primarily due to delays in a significant Nigeria project. The company anticipates a stronger second half with expected revenues from ongoing projects in Nigeria and the Middle East, along with increased recurring media sales. Despite the initial setback, MYCELX remains on track to meet its full-year financial guidance, supported by strategic operational progress and new contracts, including a notable PFAS treatment system for the U.S. Department of Defence. The engagement of industry expert Jim Summers is expected to bolster the company’s growth in the Permian Basin, enhancing its position in the water treatment market.
More about MyCelx Technologies
MYCELX Technologies Corporation operates in the clean water and clean air technology industry, focusing on advanced solutions for water treatment. The company is engaged in projects like the Nigeria REGEN and Middle East EOR, and has a market focus on recurring media sales and innovative treatment systems for sectors such as oil production and PFAS management.
Average Trading Volume: 99,157
Technical Sentiment Signal: Sell
Current Market Cap: £5.81M
See more insights into MYX stock on TipRanks’ Stock Analysis page.